期刊文献+

益肾活血方对糖尿病肾病大鼠肾组织中转化因子-β_1/p38丝裂原活化蛋白激酶信号传导的影响 被引量:7

Effect of Yishen Huoxue Recipe on Renal Transforming Growth Factor-βeta 1/p38 Mitogen-activated Protein Kinase Signal Transduction Pathway in Diabetic Nephropathy Rats
原文传递
导出
摘要 【目的】探讨益肾活血方对糖尿病肾病(DN)大鼠肾组织中转化因子-β1/p38丝裂原活化蛋白激酶(TGF-β1/p38MAPK)表达的影响。【方法】选用SD大鼠,随机分为正常组、模型组、治疗组(给予19.5 g.kg-1.d-1的益肾活血方药液灌胃),采用链脲佐菌素(55 mg/kg)一次性腹腔注射复制DN模型。采用全自动生化分析仪检测各组大鼠24 h尿蛋白、血肌酐(Scr)、尿素氮(BUN)、血清白蛋白(ALB)、血糖水平;Leica Qwin Plus图像分析系统测量肾小球直径、肾小管短径和完整肾小管数目,并称取各组大鼠左肾质量、计算肥大指数;过碘酸雪夫反应(PAS)染色观察各组大鼠肾组织病理变化;免疫组织化学法检测肾组织TGF-β1、p38MAPK表达。【结果】治疗组能够降低模型大鼠肾组织TGF-β1、p38MAPK的表达及24 h尿蛋白、Scr、BUN、血糖水平,升高ALB水平,缩小肾小球直径及肾小管短径,增加完整肾小管数量,改善肾组织病理变化,降低肾质量及肥大指数,与模型组比较差异均有统计学意义(P<0.05或P<0.01)。【结论】益肾活血方可能通过影响DN大鼠肾组织TGF-β1/p38MAPK的表达而改善上述生化指标,减轻肾脏病理损害。 Objective To investigate the influence of Yishen Huoxue Recipe (YHR), a Chinese herbal prescription with the actions of tonifying kidney and activating blood, on the renal transforming growth factor beta 1/p38 mitogen-activated protein kinase (TGF-β1/p38MAPK) expression levels in rats with diabetic nephropathy (DN). Methods SD rats were randomized into normal group, model group, and YHR group (in the dose of 19.5g·k^-1·d^-1). DN rat model was induced by one-dose intraperitoneal injection of 55 mg/kg of streptozocin.Automatic biochemical analyzer was used to detect 24-hour urinary protein, serum creatinine (SCr), blood urea nitrogen (BUN), plasma albumin (ALB), blood glucose level of the experimental rats, and Leica Qwin Plus image analysis system was used for the measurement of glomerular diameter, tubular short diameter and the number of complete tubular. The weight of rat left kidney was measured to calculate the hypertrophy index. Rat renal pathology was observed after periodic acid-Schiff staining, and renal TGF-β1 and p38MAPK expression levels were detected with immunohistochemal assay. Results After treatment, TGF-β1 and p38MAPK expression levels, 24-h urinary protein, Scr, BUN, and blood glucose were decreased, ALB was increased, glomerular diameter and tubular short diameter were shortened, the number of complete tubular was increased, renal pathology was improved, and kidney weight and hypertrophy index with the model group ). Conclusion YHR can pathological injury through the regulation of TGF-β1 were reduced in YHR group (P 〈0.05 or P 〈0. 01 compared improve the biochemical parameters and relieve the renal and p38MAPK expression.
出处 《广州中医药大学学报》 CAS 北大核心 2012年第6期691-694,698,共5页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 河南省科技厅科技攻关资助项目(编号:0412002100)
关键词 益肾活血方 药理学 糖尿病肾病 中药疗法 TGF-β1 P38MAPK 病理学 疾病模型 动物 大鼠 YISHEN HUOXUE RECIPE/pharmacology DIABETIC NEPHROPATHY/TCD therapy TGF-B1/P38MAPK KIDN.EY/pathology DISEASE MODELS, ANIMAL RATS
  • 相关文献

参考文献15

  • 1王丽晖,段惠军.MAPK信号转导途径与糖尿病肾病[J].国外医学(内科学分册),2005,32(6):234-237. 被引量:4
  • 2李玉山,刘丽秋.实验性2型糖尿病肾病大鼠模型研究[J].中国实验诊断学,2009,13(5):574-577. 被引量:25
  • 3Nakamura J, Fukui M, Ebibara I,et al. mRNA expression of growth factors in glomerular from diabetic rats [ J ]. Diabetes, 1993, 42 (3) : 450.
  • 4Nacu N,Luzina I G, Highsmith K, et al. Macrophages produce TGF- | beta | -induced ( | beta-ig-h3 | ) following ingestion ofapoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts [ J]. Immunol, 2008 , 180 : 5036.
  • 5Chiarelli F,Gaspari S,Marcovecchio M L Role of growth factors in diabetic kidney disease [ J ]. Horm Metab Res, 2009,41(8): 585.
  • 6Cavaletti G,Miloso M, Nicolinl G, et al. Emerging role of mitogen-activated protein kinase in peripheral neuropathies [ J ]. Peripher Nerv Syst, 2007,12 (3): 175.
  • 7Fujita H, Omori S, Ishikura K, et al. ERK and p38 mediatedhigh-glucose induced hypertrophy and TGF-beta expressionin renal tubular cells [ J]. Am J Physiol Renal Physiol,2004,286 (1): F120.
  • 8祝胜郎,陈结慧,蒋莹,常巨平.丝裂原活化蛋白激酶38在糖尿病小鼠肾组织中的表达[J].中国基层医药,2010,17(22):3028-3030. 被引量:3
  • 9Sakai N, Wada T,Furuichi K, et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy [J]. Am J Kidney Dis, 2005,45 (1) : 54.
  • 10Weigert C, Brodbeck K, Klopfer K, et al. Angiotensin II induces human TGF-^1 promoter activation: similarity to hyperglycaemia [J]. Diabetologia, 2002, 45 (6) : 890.

二级参考文献99

  • 1成玉斌,罗仁,胡志飞,欧春泉.糖尿病肾病中医辨证分型荟萃分析[J].中国中医基础医学杂志,2000,6(5):49-52. 被引量:40
  • 2冯健春,倪青.时振声教授治疗糖尿病肾病经验述要[J].辽宁中医杂志,1996,23(12):534-535. 被引量:74
  • 3黄淑妍,陈澍,刘雪芳,张一萍,钟艺.缬沙坦对糖尿病大鼠肾脏nephrin表达的影响[J].中国基层医药,2006,13(12):1967-1969. 被引量:2
  • 4王竹兰 冯根宝 等.642例糖尿病患者肾脏病变的调查及其临床分析[J].中国糖尿病杂志,1995,3(1):7-7.
  • 5张伯臾.中医内科学[M].上海:上海科学技术出版社,1997:258~259
  • 6Mogensen CE. Early glomerular hyperfihralion in insulin-dependent diabetics and late nephropathy[J].Scand J Clin Lab Invest,1986,46(3):201-206.
  • 7Danda RS, Habiba NM, Rincon-Choles H, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes[ J]. Kidney International, 2005,68 (6) :2562.
  • 8Hafner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the Homa model J.The Mexico city diabetes study[J]. Diabetes Care, 1996, 19(10) : 1138.
  • 9Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome M[ J]. Nature, 2006,444( 7121 ) :881.
  • 10Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes[J]. Nature,2006,444(7121 ) :840.

共引文献122

同被引文献50

  • 1易兰兰,徐静.蛋白激酶C和糖尿病肾病[J].医学综述,2006,12(3):154-156. 被引量:9
  • 2姜华军,刘建社,朱忠华,王全胜,张晓丽,王玉梅,冯玉锡.坎地沙坦对糖尿病肾病小鼠血清和糖皮质激素诱导的蛋白激酶1表达的影响及意义[J].中国药理学通报,2006,22(5):547-551. 被引量:20
  • 3Wang J P, Huang H Q, Liu P Q, et al. Inhibition of phosphoryla-tion of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats[J]. Eur J Pharmacol, 2006,553 : 297.
  • 4郎志芳,刘兰涛,王洪伟,等.绞股蓝对2型糖尿病大鼠肾脏组织中MMP-9与TIMP-1表达的影响[J].中国药物经济学,2013,(6):201-202.
  • 5Idris I,Gray S,Donnelly R.Protein kinase C activation;Isozyme-specific effects on metabolism and cardiovascular complications in diabetes[J].Diabetologia,2001,44(6):659-6731.
  • 6Craven P A,de Rubertis F R.Protein kinase C is activated in glomeruli from streptozotocin diabetic rats.Possible mediation by glucose[J].Clin Invest,1998,83(5):1667-16751.
  • 7李艳平,保春华.丹参酮Ⅱ A通过阻断MAPK抑制糖尿病大鼠血管平滑肌细胞增殖[J].基础医学与临床,2007,27(12):1370-1372. 被引量:3
  • 8黎磊石,刘志红.中国肾脏病学[M].北京:中国军医出版社,2008:1467-1471.
  • 9Wiggins RC. The spectrum of podocytopathies : a unifying view of glomerular diseases[ J]. Kidney Int,2007,71 (12) : 1205-1214.
  • 10Siu B, Saha J. Reduction in podocyte density as a pathologic feature in early diabetic rephropathy in rodents: prevention by lipoic acid treatment [ J]. BMC Nephro1,2006,7 ( 1 ) :6.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部